Using just one of the two drugs makes it easier for the bacterium to develop resistance.

The letter, which is also signed by chief pharmaceutical officer Dr Keith Ridge, stated: "Gonorrhoea has rapidly acquired resistance to new antibiotics, leaving few alternatives to the current recommendations.

"It is therefore extremely important that suboptimal treatment does not occur."

What is Gonorrhoea?

The disease is caused by the bacterium called Neisseria gonorrhoeae.

The infection is spread by unprotected vaginal, oral and anal sex.

Symptoms can include a thick green or yellow discharge from sexual organs, pain when urinating and bleeding between periods. Often the person has no symptoms, however, but can still easily spread the disease to others.

Untreated infection can lead to infertility, pelvic inflammatory disease and can be passed on to a child during pregnancy.

Gonorrhoea is the second most common sexually transmitted infection in England and cases are soaring.

The number of infections increased by 19% from 29,419 in 2013 to 34,958 the following year.

Dr Jan Clarke, the president of BASHH, told the BBC News website: "We're really pleased that the chief medical officer has stressed that gonorrhoea needs this approach to treatment due to the rapid development of resistance.

"We need to protect what we've got and we need to encourage pharmacists and general practitioners to follow first-line treatment."

Dr Andrew Lee, from Public Health England, added: "Investigations are ongoing into a number of cases of anti-microbial resistant gonorrhoea.

"Public Health England will continue to monitor, and act on, the spread of antimicrobial resistance and potential gonorrhoea treatment failures, to make sure they are identified and managed promptly."

Follow by Email

Hire Workers

Like Us On Facebook

Completing this form confirms you wish to receive email communications. You can securely opt-out at any time. I agree to give Dr. Jerry - the First permission to send me future emails. I understand I can opt-out at any time in the future.